Stockadora

8-K filings / November 17, 2026

Pacira BioSciences, Inc.: A stock exchange listing notice

Pacira BioSciences, Inc. filed a current report (Form 8-K) with the SEC on November 17, 2026. It reports a stock exchange listing notice.

Item 3.01

Stock exchange listing notice

  • Exchange Nasdaq From the filing
    Source
    “On November 17, 2026, the Company notified The Nasdaq Global Select Market (“Nasdaq”) of the consummation of the Merger, and requested that Nasdaq (i) halt trading of the Shares prior to market open on November 17, 2026 and (ii) file with the SEC a Notification of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), on Form 25 to effect the delisting of the Shares from Nasdaq and to deregister the Shares under Section 12(b) of the Exchange Act.”
    Read by code from this sentence of the filing.
  • What it says The stock leaves the exchange after a merger From the filing
    Source
    “On November 17, 2026, the Company notified The Nasdaq Global Select Market (“Nasdaq”) of the consummation of the Merger, and requested that Nasdaq (i) halt trading of the Shares prior to market open on November 17, 2026 and (ii) file with the SEC a Notification of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), on Form 25 to effect the delisting of the Shares from Nasdaq and to deregister the Shares under Section 12(b) of the Exchange Act.”
    Read by code from this sentence of the filing.
  • Notice date November 17, 2026 From the filing
    Source
    “On November 17, 2026, the Company notified The Nasdaq Global Select Market (“Nasdaq”) of the consummation of the Merger, and requested that Nasdaq (i) halt trading of the Shares prior to market open on November 17, 2026 and (ii) file with the SEC a Notification of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), on Form 25 to effect the delisting of the Shares from Nasdaq and to deregister the Shares under Section 12(b) of the Exchange Act.”
    Read by code from this sentence of the filing.
Not investment advice.Read the filing on SEC.gov

Item 5.02

Officers and directors

The filing also carries this item, but our code could not read it surely, so its facts are not shown here.

Not investment advice.Read the filing on SEC.gov

Facts read from the filing's own text; a fact the filing does not state clearly is left out. All documents of this filing on SEC.gov.